Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone · Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response Start date pushed from Sep 2026 to Nov 2026
- Notable: S-606001 · Late-onset Pompe Disease (LOPD) Start date pushed from Nov 2, 2026 to Mar 31, 2027
- Notable: Urine Volatile Organic Compounds for Disease Detection Eligibility criteria changed
- Notable: Epcoritamab as Consolidative Therapy for Waldenstr(SqrRoot)(Delta)m Macroglobulinemia (WM) Treated With a Bruton Tyrosine Kinase Inhibitor (BTKi) Eligibility criteria changed
- Notable: Quanduzhong Capsules for Primary Osteoporosis Start date pushed from Oct 15, 2026 to Dec 15, 2026
- Notable: LLM-Generated Medical Summaries During Hospitalization to Improve Patient Activation in High-Risk Pregnancies Start date pushed from Oct 1, 2026 to Dec 1, 2026
- Notable: Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study Enrollment increased: 1 → 946 participants
- Notable: Rapamycin in Ovarian Aging Results posted: Nov 18, 2026
- Notable: LM11A-31 Safety and Tolerability in Aging People Living With HIV and Neurocognitive Impairment Eligibility criteria changed
- Notable: PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease Enrollment increased: 80 → 120 participants
- Notable: Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome Start date pushed from Sep 2026 to Nov 30, 2026
- Notable: GMDTC Injection · Solid Tumors and Cisplatin-Induced Renal Dysfunction Start date pushed from Oct 2026 to Dec 2026
- Notable: Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer Primary completion date changed from estimate of Jan 1, 2026 to Nov 1, 2026
- Notable: Topical CBD Scar Healing Study Start date pushed from Sep 2026 to Dec 2026
- Notable: [18F]ZDG2 First-in-Human PET Imaging in PAH Eligibility criteria changed
- Notable: De-escalation of Axillary Dissection for Node-positive Breast Cancer Start date pushed from Oct 15, 2026 to Jan 15, 2027
- Notable: Piloting FUERTE · Federally qUalified Health Centers Engaging Hispanic Men at Risk of diabeTEs Start date pushed from Oct 2026 to Dec 2026
- Notable: Advancing Cardiovascular Health · Intellectual Disabilities: Co-Development of Technology Interventions to Enhance Physical Activity Start date pushed from Nov 30, 2026 to Jun 30, 2027
- Notable: Sight and Hearing Investigation Into Effects on Delirium Results posted: Nov 18, 2026
- Notable: Rotational Atherectomy and Drug-Coated Balloon Angioplasty With Embolic Protection for Superficial Femoral Artery Occlusions Start date pushed from Sep 1, 2026 to Dec 1, 2026
- Notable: Acceptability of AI-Personalized Virtual Reality Picture Books for Hospitalized Pediatric Patients Start date pushed from Oct 1, 2026 to Nov 30, 2026
- Notable: Walking Balance Training Post-Stroke Results posted: Nov 18, 2026
- Notable: Mobile Contingency Management for Smoking Cessation Results posted: Nov 18, 2026
- Notable: Management of Intractable Trigeminal Neuralgia of Multiple Sclerosis Patients <Bassiouni Technique> Start date pushed from Aug 31, 2026 to Nov 29, 2026
- Notable: Serum Electrolytes and Contrast-Induced Nephropathy in Acute Ischemic Stroke Patients Undergoing Endovascular Treatment Primary completion date changed from estimate of May 10, 2026 to Nov 10, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates